Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Real Clean Distribuciones SA de CV
WARNING LETTER
•Real Clean Distribuciones SA de CV•July 23, 2020

FDA WARNING_LETTER - Real Clean Distribuciones SA de CV - July 23, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA issued a Warning Letter to Real Clean Distribuciones SA de CV following the detention and refusal of Born Basic Anti-Bac Hand Sanitizer at the U.S. border. FDA testing revealed the product, labeled to contain 70% ethyl alcohol, actually contained an average of 45% ethanol and 24% methanol. This constitutes adulteration under section 501(d)(2) of the FD&C Act due to active ingredient substitution with a dangerous chemical, and under 501(a)(2)(B) for demonstrating a failure in the firm's quality assurance and CGMP compliance. The product is also an unapproved new drug under section 505(a) as it is not generally recognized as safe and effective (GRASE) and lacks FDA approval. Furthermore, it is misbranded under sections 502(j), (a), (e), and (ee) because it is dangerous to health, falsely labeled regarding active ingredients, fails to list methanol, and does not comply with nonprescription drug marketing requirements under section 505G. The introduction of such adulterated and misbranded drugs into interstate commerce is prohibited. The FDA strongly recommends engaging a qualified CGMP consultant to evaluate operations and assist with corrective actions. All drugs manufactured by the firm were placed on Import Alert 66-78, subjecting them to detention without physical examination. The firm must respond within 15 working days detailing corrective actions and a completion schedule.

Company
Real Clean Distribuciones SA de CV
Inspection Date
July 23, 2020
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Francis Godwin (Director)
  • Jennifer L. Diaz
Open in Dashboard

ID · a12c6c58-d370-449f-b7dc-f8be673d08e3

Violation Codes10
21 U.S.C. 351(d)(2)21.U.S.C. 355(a)21 U.S.C. 352(j)21 U.S.C. 352(a)21 U.S.C. 352(e)21 U.S.C. 352(ee)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.